4830
H. Li, R.A. Widenhoefer / Tetrahedron 66 (2010) 4827–4831
1H), 2.38 (s, 3H), 1.94 (m, 2H), 1.48 (septet, J¼6.8 Hz, 1H), 1.20
4.4. Syntheses of bicyclic ureas
(pentet, J¼6.8 Hz, 2H), 0.82 (t, J¼7.2 Hz, 3H). 13C{1H} NMR:
d 152.4,
144.4, 136.7, 135.9, 129.6, 126.9, 116.5, 42.6, 39.1, 35.5, 23.7, 21.4,
10.8. IR (neat, cmꢁ1): 3336, 3100, 1654, 1547, 1347, 1162, 1089, 893,
813, 664. Anal. calcd (found) for C27H28N2O: H, 7.14 (7.21); C, 58.04
(58.05).
4.4.1. Synthesis of compound 2b. A suspension of 1 (43 mg,
0.10 mmol), NIS (45 mg, 0.20 mmol), and NaHCO3 (8.4 mg,
0.10 mmol) in toluene (1.0 mL) was stirred at room temperature for
2 h. The crude reaction mixture was loaded directly onto a silica gel
column and chromatographed (SiO2; hexanes–EtOAc¼3:1) to give
2b (40 mg, 91%). TLC (hexanes–EtOAc¼3:1): Rf¼0.4. 1H NMR:
d 7.92
4.3. Synthesis of bicyclic isoureas
(d, J¼8.0 Hz, 2H), 7.34 (d, J¼8.0 Hz, 2H), 7.31–7.12 (m, 10H), 4.10–
4.07 (m, 2H), 3.93 (tt, J¼5.5, 10 Hz, 1H), 3.88 (d, J¼11.5 Hz, 1H), 3.65
(dd, J¼5.5, 9.5 Hz, 1H), 2.57 (dd, J¼5.0, 11.5 Hz, 1H), 2.47 (s, 3H), 2.26
4.3.1. Compound 2a17. A suspension of 1 (43 mg, 0.10 mmol), NIS
(45 mg, 0.20 mmol), and AgOTf (1.3 mg, 4.7ꢂ10ꢁ3 mmol) in tolu-
ene (1.0 mL) was stirred for 14 h at room temperature. The crude
reaction mixture was loaded directly onto a silica gel column and
chromatographed (hexanes–EtOAc¼1:1) to give 2 (42 mg, 95%).
(dd, J¼9.5, 12.0 Hz, 1H). 13C{1H} NMR:
d 156.3, 145.5, 145.3, 144.8,
135.0, 129.7, 128.6, 128.1, 126.8, 126.78, 126.5, 56.9, 56.2, 54.1, 48.0,
43.7, 21.7.
Remaining imidizolidin-2-ones were synthesized employing
procedures similar to that used to synthesize 2b. The 1H and 13C
NMR spectra of known compounds 6b–8b,18 16b,18 19b,17 20b,18
and 24b12 were identical to reported spectra.
TLC (hexanes–EtOAc¼1:1): Rf¼0.3. 1H NMR:
d
7.85 (d, J¼8.5 Hz,
2H), 7.32–7.14 (m, 12H), 4.70 (t, J¼9.0 Hz, 1H), 4.35 (dd, J¼7.0,
9.0 Hz, 1H), 4.31 (d, J¼11.0 Hz, 1H), 4.16 (m, 1H), 3.90 (d, J¼11.0 Hz,
1H), 2.59 (dd, J¼5.0, 11.5 Hz, 1H), 2.41 (dd, J¼10.0, 11.0 Hz, 1H), 2.40
(s, 3H). 13C{1H} NMR:
d
160.5, 144.9, 144.6, 142.5, 139.4, 129.2,
4.4.2. Compound 12b. TLC (hexanes–EtOAc¼3:1): Rf¼0.3. 1H NMR:
128.7, 128.6, 127.2, 127.1, 126.9, 126.7, 126.4, 73.3, 58.7, 58.2, 57.2,
43.1, 21.6.
Remaining bicyclic isoureas were synthesized employing pro-
cedures similar to that used to synthesize 2a. The 1H and 13C NMR
spectra of known compounds 6a–8a,17 12a,18 19a,18 and 20a18 were
identical to reported spectra.
d
7.92 (d, J¼10.0 Hz, 2H), 7.32 (d, J¼10.0 Hz, 2H), .26–7.17 (m, 3H),
7.06 (d, J¼8.5 Hz, 1H), 4.02 (dd, J¼10.0, 12.0 Hz, 1H), 3.90–3.81 (m,
2H), 3.53–3.44 (m, 3H), 2.42 (s, 3H), 2.34 (m, 1H), 1.47 (dd, J¼13.0,
28.5 Hz, 1H). 13C{1H} NMR:
d 156.4, 144.9, 141.0, 135.1, 129.7, 128.7,
128.0, 127.0, 126.9, 56.4, 52.0, 46.9, 45.5, 40.1, 21.7. IR (neat, cmꢁ1):
2963, 1725, 1359, 1166, 1091, 759, 702, 662. Anal. Calcd (found) for
C20H22N4O5S: H, 5.15 (4.96); C, 55.80 (55.67).
4.3.2. Compound 13a. TLC (hexanes–EtOAc¼1:1): Rf¼0.2. 1H NMR:
d
7.77 (d, J¼8.4 Hz, 2H), 7.17 (d, J¼8.4 Hz, 2H), 4.58 (dd, J¼8.0,
4.4.3. Compound 13b. TLC (hexanes–EtOAc¼1:1): Rf¼0.7. 1H NMR:
9.2 Hz,1H), 4.26 (dd, J¼5.2, 9.2 Hz,1H), 4.01 (tdd, J¼5.6, 8.0.10.8 Hz,
1H), 3.33 (dd, J¼8.8, 11.2 Hz, 1H), 3.18 (dd, J¼8.8, 11.2 Hz, 1H), 2.33
(s, 3H), 2.12–2.02 (m, 2H), 1.48 (septet of doublets, J¼6.4, 8.8 Hz,
1H), 1.12 (q, J¼10.8 Hz, 1H), 0.82 (d, J¼6.8 Hz, 3H). 13C{1H} NMR:
d
7.84 (d, J¼8.5 Hz, 2H), 7.25 (d, J¼8.5 Hz, 2H), 3.90 (dd, J¼9.0,
11.0 Hz, 1H), 3.66 (m, 2H), 3.10 (dd, J¼3.0, 9.0 Hz, 2H), 2.36 (s, 3H),
1.92 (m, 2H), 1.36 (tdd, J¼6.5, 9.0, 13.5 Hz, 1H), 0.95 (q, J¼11.5 Hz,
1H), 0.78 (d, J¼7.0 Hz, 6H). 13C{1H} NMR:
d 156.2, 144.7, 135.1, 129.6,
d
160.4, 142.4, 139.9, 129.1, 129.0, 127.03, 126.99, 72.9, 60.9, 60.8,
127.9, 56.1, 49.3, 47.9, 47.1, 36.2, 32.5, 21.6, 21.2, 21.1. IR (neat, cmꢁ1):
2964, 1726, 1387, 1356, 1168, 1095, 821, 662. Anal. Calcd (found) for
C13H15N3O3: H, 6.88 (6.92); C, 59.60 (59.51).
50.6, 49.4, 36.1, 32.4, 21.5, 21.2. IR (neat, cmꢁ1): 2956, 1596, 1426,
1277, 1147, 857, 682, 614. Anal. Calcd (found) for C20H22N4O5S: H,
6.88 (6.86); C, 59.60 (59.50).
4.4.4. Compound 14b. TLC (hexanes–EtOAc¼3:1): Rf¼0.7. 1H NMR:
4.3.3. Compound 14a. TLC (hexanes–EtOAc¼1:1): Rf¼0.3. 1H NMR:
d
7.89 (d, J¼8.0 Hz, 2H), 7.30 (d, J¼8.0 Hz, 2H), 3.95 (dd, J¼8.5, 9.5 Hz,
d
7.79 (d, J¼8.0 Hz, 2H), 7.20 (d, J¼8.0 Hz, 2H), 4.62 (t, J¼9.2, 1H),
1H), 3.70 (m, 1H), 3.18 (dd, J¼8.5, 11.5 Hz, 1H), 3.08 (dd, J¼8.0,
11.5 Hz, 1H), 2.41 (s, 3H), 2.22–2.14 (m, 1H), 2.11–2.06 (m, 1H), 1.33
(m, 2H), 0.98 (q, J¼10.5, 1H), 0.84 (t, J¼8.0 Hz, 3H). 13C{1H} NMR:
4.28 (dd, J¼6.0, 9.2 Hz, 1H), 4.06 (m, 1H), 3.37 (dd, J¼8.8, 10.8 Hz,
1H), 3.16 (dd, J¼8.8, 10.8 Hz, 1H), 2.36 (s, 3H), 2.30 (m, 1H), 2.13 (td,
J¼5.6, 11.6 Hz, 1H), 1.38 (pentet, J¼7.2 Hz, 2H), 1.11 (q, J¼10.8 Hz,
d
156.4, 144.8, 135.1, 129.7,128.0, 55.9, 50.4, 47.3, 42.1, 37.6, 27.1, 21.7,
1H), 0.86 (t, J¼7.2 Hz, 3H). 13C{1H} NMR:
d
160.5, 142.3, 139.8, 129.0,
12.6. IR (neat, cmꢁ1): 2962, 1726, 1358, 1165, 1092, 757, 662. Anal.
Calcd (found) for C20H22N4O5S: H, 5.15 (4.96); C, 55.80 (55.67).
126.9, 73.1, 60.6, 51.6, 43.4, 37.4, 26.8, 21.4, 12.5. IR (neat, cmꢁ1):
2961, 1585, 1440, 1284, 1152, 1080, 859, 823, 666, 613. Anal. Calcd
(found) for C20H22N4O5S: H, 5.15 (4.96); C, 55.80 (55.67).
4.5. Assignment of product relative configuration
4.3.4. Compound 16a. TLC (hexanes–EtOAc¼1:1): Rf¼0.3. 1H NMR:
The relative configuration of 13b was established by the pres-
ence of a strong cross peak relating tertiary proton Ha to bridgehead
proton Hb in the 1H–1H NOESY spectrum. The relative configura-
tions of compounds 12b, 14b, and 12a–14a were assigned based on
analogy to 13b. The relative configurations of compounds 19a, 19b,
20a, and 20b were assigned from the published spectra.17,18
d
7.79 (d, J¼8.4 Hz, 2H), 7.20 (d, J¼8.4 Hz, 2H), [4.29, 4.25, ABq,
J¼8.8 Hz, 2H], 3.77 (d, J¼12.4 Hz, 1H), 2.81 (d, J¼12.4 Hz, 1H), 2.36
(s, 3H), [1.67, 1.58, ABq, J¼13.2 Hz, 2H], 1.47–1.27 (m, 8H), 1.32 (s,
3H), 1.15–1.03 (m, 2H). 13C{1H} NMR:
d 161.5, 142.2, 139.8, 128.9,
126.9, 81.1, 66.2, 56.4, 50.2, 45.9, 37.5, 36.5, 26.8, 25.3, 23.8, 22.9,
21.5. IR (neat, cmꢁ1): 2925, 1595, 1311, 1156, 816, 663. Anal. Calcd
(found) for C20H22N4O5S: H, 5.15 (4.96); C, 55.80 (55.67).
O
i-Pr
Ha
N
13b
NTs
4.3.5. Compound 22a. TLC (hexanes–EtOAc¼3:1): Rf¼0.6. 1H NMR:
d
8.13 (d, J¼8.0 Hz, 2H), 7.38 (d, J¼8.0 Hz, 2H), 7.31–7.18 (m, 10H),
Hb
4.90 (br d, J¼14.0, 1H), 4.56 (m, 1H), 3.79 (m, 2H), 3.05 (dd, J¼1.2,
14.0 Hz, 1H), 2.75 (br d, J¼13.6 Hz, 1H), 2.37 (dt, J¼2.8, 13.6 Hz, 1H),
1.91 (qd, J¼2.8, 13.2 Hz, 1H), 1.25 (br q, J¼13 Hz, 1H). 13C{1H} NMR:
NOE
d
155.0, 152.6, 146.5, 143.8, 142.0, 128.6, 128.5, 127.7, 126.7, 126.5,
Acknowledgements
126.3, 124.7, 123.8, 71.5, 55.1, 50.0, 46.0, 33.8, 26.1. IR (neat, cmꢁ1):
1648, 1567, 1495, 1316, 1265, 1002, 859, 697. HRMS calcd (found) for
C25H23N3O3 (Mþ): 413.1739 (413.1756).
Acknowledgement made to the NIH (GM-080422) for support of
this research.